Skip to Content

Tag: PharMedica

Also Noted

PharMerica sells to investment firm

December 8, 2017HME News Staff

LOUISVILLE, Ky. - PharMerica, a specialty pharmacy services provider, has been acquired by global investment firm KKR and Walgreens Boots Alliance, it announced Dec. 7. PharMerica shareholders will receive an amount in cash equal to $29.25 per share of PharMerica common stock, without interest, and its stock will cease trading on the NYSE, according to a press release. PharMerica operates 96 institutional pharmacies, 20 specialty home infusion pharmacies and 5 specialty oncology pharmacies in 45...

Home Infusion, Investment, Mergers & Acquisitions (M&A), PharMedica

Read Full Articlered right arrow icon